image
Bio-Techne Corporation TECH
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 67.57
-6.85 %
$ 10.7 B
Market Cap
71.13
P/E
INCOME STATEMENT
1.16 B REVENUE
1.97%
Growth Rates
1Year 1.97%
3Years 7.58%
5Years 10.17%
7Years 10.87%
10Years 12.47%
207 M OPERATING INCOME
-30.86%
Growth Rates
1Year -30.86%
3Years 11.39%
5Years 10.48%
7Years 7.85%
10Years 2.61%
168 M NET INCOME
-41.12%
Growth Rates
1Year -41.12%
3Years 6.39%
5Years 11.84%
7Years 11.99%
10Years 4.24%
EFFICIENCY
Earnings Waterfall Bio-Techne Corporation
image
Revenue 1.16 B
Cost Of Revenue 386 M
Gross Profit 773 M
Operating Expenses 563 M
Operating Income 207 M
Other Expenses 38.6 M
Net Income 168 M

Income Statement

Millions
Jun-2024 Jun-2023 Jun-2022 Jun-2021 Jun-2020 Jun-2019 Jun-2018 Jun-2017 Jun-2016 Jun-2015 Jun-2014 Jun-2013 Jun-2012 Jun-2011 Jun-2010 Jun-2009 Jun-2008 Jun-2007 Jun-2006 Jun-2005 Jun-2004 Jun-2003 Jun-2002 Jun-2001 Jun-2000 Jun-1999 Jun-1998 Jun-1997 Jun-1996 Jun-1995 Jun-1994 Jun-1993 Jun-1992 Jun-1991 Jun-1990 Jun-1989
REVENUE
Revenue 1 159.1 1 136.7 1 105.6 931.0 738.7 714.0 643.0 563.0 499.0 452.2 357.8 310.6 314.6 290.0 269.0 264.0 257.4 223.5 202.6 178.7 161.3 145.0 130.9 115.4 103.8 90.9 67.3 60.9 54.6 47.7 40.3 28.7 22.3 19.3 15.7 12.5
GROSS PROFIT
Cost Of Revenue 386.0 366.9 349.1 298.2 255.5 240.5 210.8 188.5 162.4 145.0 106.4 79.5 78.8 65.0 54.5 55.5 52.9 46.7 45.7 36.8 34.9 35.4 32.5 28.4 23.3 25.0 17.8 17.0 17.1 16.8 15.2 11.8 9.6 8.9 7.3 6.1
Gross Profit 773.1 769.8 756.5 632.9 483.2 473.5 432.1 374.5 336.7 307.3 251.4 231.1 235.8 224.9 214.6 208.5 204.5 176.8 156.9 141.8 126.4 109.6 98.4 86.9 80.5 65.9 49.5 43.9 37.5 30.9 25.1 16.9 12.7 10.4 8.4 6.4
OPERATING INCOME
Operating Expenses 563.0 470.9 459.9 395.6 325.8 326.8 296.0 252.8 186.1 160.3 91.7 74.8 71.7 61.9 58.3 57.7 60.2 52.7 48.4 44.1 44.1 41.9 45.6 41.1 41.2 40.8 28.3 28.6 25.3 21.5 17.5 10.0 8.6 8.2 6.9 5.8
Selling, General and Administrative Expenses 466.4 378.4 372.8 325.0 260.6 264.4 240.6 199.2 140.9 119.4 60.7 43.4 41.7 35.9 32.2 33.2 36.7 31.0 27.6 24.5 21.7 19.4 19.6 17.7 17.3 16.9 15.4 14.6 13.0 11.2 9.2 8.7 7.6 7.7 6.6 5.6
Research and Development Expenses 96.7 92.5 87.1 70.6 65.2 62.4 55.3 53.5 45.2 40.9 30.9 29.3 27.9 26.0 25.1 23.6 22.4 20.1 18.8 18.4 20.8 20.6 17.5 14.5 11.2 12.0 10.6 11.7 10.4 8.6 6.5 0 0 0 0 0
Operating Income 206.7 298.9 296.6 149.5 74.7 125.6 136.2 121.8 150.6 147.0 159.8 158.5 166.2 163.1 156.3 150.8 144.3 124.2 108.5 97.8 82.3 67.7 52.8 45.8 39.3 25.1 21.2 15.3 12.2 9.4 7.6 6.9 4.1 2.2 1.5 0.6
PRE-TAX INCOME
Interest Income Expense 15.7 11.2 11.3 14.0 19.2 21.7 10.2 7.4 1.7 1.5 0 0 0 0 0 0 0 1.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Other Income (21.0) 39.7 4.8 (89.1) 119.1 (34.7) (10.2) (8.6) (3.1) 7.1 1.6 2.2 (4.0) 1.9 0.1 4.6 9.5 4.8 2.7 2.1 0.3 1.8 (15.1) 2.0 67 K 1.0 1.2 0.7 0.4 0.2 (0.4) (0.4) (0.8) 0 100 K 0
Pre-Tax Income 185.7 338.7 301.4 148.2 276.5 112.0 126.0 113.2 147.5 154.2 161.4 160.7 162.2 165.0 156.4 155.4 153.8 128.9 111.2 99.9 82.5 69.6 37.7 47.8 39.4 26.1 22.4 16.0 12.6 9.6 7.2 6.5 3.3 2.2 1.4 0.6
NET INCOME
Tax Provision 17.6 53.2 38.3 8.6 47.2 15.9 0.6 35.9 43.0 46.4 50.4 48.1 49.9 52.7 46.7 50.1 50.3 43.8 37.8 33.8 29.6 24.2 10.6 13.8 12.8 9.4 7.2 5.1 4.0 2.9 2.1 2.1 1.3 0.6 0.4 0.2
Net Income 168.1 285.3 272.1 140.4 229.3 96.1 125.3 77.3 104.5 107.7 110.9 112.6 112.3 112.3 109.8 105.2 103.6 85.1 73.4 66.1 52.9 45.4 27.1 34.0 26.6 16.7 15.2 10.9 8.6 6.7 5.1 4.4 2.0 1.6 1.0 0.4
EPS 1.07 1.81 1.73 0.91 1.5 0.64 0.84 0.52 0.7 0.73 0.75 0.76 0.76 0.76 0.74 0.7 0.66 0.54 0.47 0.41 0.32 0.27 0.16 0.21 0.16 0.1 0.1 0.0725 0.0553 0.044 0.035 0.03 0.015 0.0125 0.0075 0.0032